Literature DB >> 18516525

Intestinal tissue engineering: where do we stand?

Talat Waseem.   

Abstract

Tissue engineering has revolutionized the medical field by giving us the hope of generating alternative human tissues that could replace diseased ones. On this front, the generation of tissue-engineered neo-intestine in animal models has been a great endeavor with the ultimate goal of replacing the diseased gut or to treat short gut syndrome. Although this field and the generated neo-intestine are still in their infancy, this idea is so attractive that it has fascinated all medical personnel including gastroenterologists and gastrointestinal surgeons. We herein introduce the salient features of a tissue-engineered intestine, the hopes associated with it, and the few practical constraints in developing a "mature" human tissue-engineered intestine, which would be sufficient to treat short gut syndrome.

Entities:  

Mesh:

Year:  2008        PMID: 18516525     DOI: 10.1007/s00595-007-3671-9

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  10 in total

Review 1.  What's new in the management of short gut syndrome in children.

Authors:  B W Warner; J A Vanderhoof; J D Reyes
Journal:  J Am Coll Surg       Date:  2000-06       Impact factor: 6.113

2.  Tissue engineered small intestine: a viable clinical option?

Authors:  Brad W Warner
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

Review 3.  Review: ex vivo engineering of living tissues with adult stem cells.

Authors:  Bonnie Barrilleaux; Donald G Phinney; Darwin J Prockop; Kim C O'Connor
Journal:  Tissue Eng       Date:  2006-11

4.  Preliminary studies of tissue-engineered intestine using isolated epithelial organoid units on tubular synthetic biodegradable scaffolds.

Authors:  R S Choi; J P Vacanti
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

5.  Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome.

Authors:  B Messing; P Crenn; P Beau; M C Boutron-Ruault; J C Rambaud; C Matuchansky
Journal:  Gastroenterology       Date:  1999-11       Impact factor: 22.682

6.  Experience with longitudinal intestinal lengthening and tailoring.

Authors:  A Bianchi
Journal:  Eur J Pediatr Surg       Date:  1999-08       Impact factor: 2.191

Review 7.  Nontransplant surgical options for management of the short bowel syndrome.

Authors:  B W Warner; M S Chaet
Journal:  J Pediatr Gastroenterol Nutr       Date:  1993-07       Impact factor: 2.839

8.  Comparison of polyester scaffolds for bioengineered intestinal mucosa.

Authors:  David C Chen; Jeffrey R Avansino; Vatche G Agopian; Vicki D Hoagland; Jacob D Woolman; Sheng Pan; Buddy D Ratner; Matthias Stelzner
Journal:  Cells Tissues Organs       Date:  2006       Impact factor: 2.481

9.  Tissue-engineered small intestine improves recovery after massive small bowel resection.

Authors:  Tracy C Grikscheit; Aleem Siddique; Erin R Ochoa; Ashok Srinivasan; Eben Alsberg; Richard A Hodin; Joseph P Vacanti
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

10.  Studies of brush border enzymes, basement membrane components, and electrophysiology of tissue-engineered neointestine.

Authors:  R S Choi; M Riegler; C Pothoulakis; B S Kim; D Mooney; M Vacanti; J P Vacanti
Journal:  J Pediatr Surg       Date:  1998-07       Impact factor: 2.545

  10 in total
  3 in total

Review 1.  Regenerative surgery: tissue engineering in general surgical practice.

Authors:  Victor W Wong; Derrick C Wan; Geoffrey C Gurtner; Michael T Longaker
Journal:  World J Surg       Date:  2012-10       Impact factor: 3.352

Review 2.  ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective.

Authors:  Michela Pozzobon; Marco Ghionzoli; Paolo De Coppi
Journal:  Pediatr Surg Int       Date:  2009-09-01       Impact factor: 1.827

Review 3.  Whole-organ re-engineering: a regenerative medicine approach to digestive organ replacement.

Authors:  Hiroshi Yagi; Alejandro Soto-Gutierrez; Yuko Kitagawa
Journal:  Surg Today       Date:  2012-11-27       Impact factor: 2.549

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.